286 related articles for article (PubMed ID: 23392739)
1. A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.
McKinney DM; Southwood S; Hinz D; Oseroff C; Arlehamn CS; Schulten V; Taplitz R; Broide D; Hanekom WA; Scriba TJ; Wood R; Alam R; Peters B; Sidney J; Sette A
Immunogenetics; 2013 May; 65(5):357-70. PubMed ID: 23392739
[TBL] [Abstract][Full Text] [Related]
2. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of CD4
Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
Front Immunol; 2020; 11():602014. PubMed ID: 33658991
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: determination of a non-DR non-DQ gene product.
Ababou A; Goyeneche J; Davis WC; Lévy D
J Leukoc Biol; 1994 Aug; 56(2):182-6. PubMed ID: 7520928
[TBL] [Abstract][Full Text] [Related]
5. Peptide binding predictions for HLA DR, DP and DQ molecules.
Wang P; Sidney J; Kim Y; Sette A; Lund O; Nielsen M; Peters B
BMC Bioinformatics; 2010 Nov; 11():568. PubMed ID: 21092157
[TBL] [Abstract][Full Text] [Related]
6. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
7. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
8. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
9. Role of human leucocyte antigen DQ in the presentation of T cell epitopes in the major cow's milk allergen alphas1-casein.
Ruiter B; Rozemuller EH; van Dijk AJ; Garssen J; Bruijnzeel-Koomen CA; Tilanus MG; Knol EF; van Hoffen E
Int Arch Allergy Immunol; 2007; 143(2):119-26. PubMed ID: 17228168
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype.
Kagnoff MF; Harwood JI; Bugawan TL; Erlich HA
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6274-8. PubMed ID: 2788285
[TBL] [Abstract][Full Text] [Related]
11. Importance of HLA-DQ and -DP restriction elements in T-cell responses to soluble antigens: mutational analysis.
Mellins E; Woelfel M; Pious D
Hum Immunol; 1987 Mar; 18(3):211-23. PubMed ID: 3032874
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
Grifoni A; Moore E; Voic H; Sidney J; Phillips E; Jadi R; Mallal S; De Silva AD; De Silva AM; Peters B; Weiskopf D; Sette A
Front Immunol; 2019; 10():1568. PubMed ID: 31333679
[No Abstract] [Full Text] [Related]
13. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.
Mollick JA; Cook RG; Rich RR
Science; 1989 May; 244(4906):817-20. PubMed ID: 2658055
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
15. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex.
Djilali-Saiah I; Benini V; Daniel S; Assan R; Bach JF; Caillat-Zucman S
Tissue Antigens; 1996 Aug; 48(2):87-92. PubMed ID: 8883297
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
17. Peptide recognition by T-cell clones of an HLA-DRB1*1501/*0901 heterozygous donor is promiscuous only between parental alleles.
Agrewala JN; Deacock S; Jurcevic S; Wilkinson R
Hum Immunol; 1997 Jun; 55(1):34-8. PubMed ID: 9328787
[TBL] [Abstract][Full Text] [Related]
18. Segregation of HLA-DR, -DQ and -DP phenotypes and restriction fragment length polymorphic fragments in two recombinant families.
Munck Petersen C; Juncker Sørensen I; Hyldig-Nielsen JJ; Lamm LU
Tissue Antigens; 1988 Aug; 32(2):104-11. PubMed ID: 2904184
[TBL] [Abstract][Full Text] [Related]
19. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.
Fontenot AP; Torres M; Marshall WH; Newman LS; Kotzin BL
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12717-22. PubMed ID: 11050177
[TBL] [Abstract][Full Text] [Related]
20. Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus.
Linner KM; Monroy C; Bach FH; Gehrz RC
Hum Immunol; 1986 Oct; 17(2):79-86. PubMed ID: 2428785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]